These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 16334763)
1. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Tokunaga Y; Takahashi K; Saito T Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763 [TBL] [Abstract][Full Text] [Related]
2. Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Tokunaga Y; Sasaki H; Saito T Surgery; 2007 Mar; 141(3):346-53. PubMed ID: 17349846 [TBL] [Abstract][Full Text] [Related]
3. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody. Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455 [TBL] [Abstract][Full Text] [Related]
4. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy. Yamada H; Iinuma H; Watanabe T Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer]. Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer. Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608 [TBL] [Abstract][Full Text] [Related]
8. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer. Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850 [TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739 [TBL] [Abstract][Full Text] [Related]
12. Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival. Saif MW; Hashmi S; Bell D; Diasio RB Expert Opin Drug Saf; 2009 Sep; 8(5):507-14. PubMed ID: 19663627 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy. Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers. Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Watanabe T; Ochiai M; Tanimura H; Tsubota YT Oncol Rep; 2004 May; 11(5):1045-51. PubMed ID: 15069545 [TBL] [Abstract][Full Text] [Related]
15. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil. Tahara M; Ochiai A; Fujimoto J; Boku N; Yasui W; Ohtsu A; Tahara E; Yoshida S Oncol Rep; 2004 Jan; 11(1):9-15. PubMed ID: 14654896 [TBL] [Abstract][Full Text] [Related]
16. [Relationships among the expression of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase and the prognosis of breast cancer]. Yu ZG; Zhen JH; Jia HY; Zhang Q; Sun JZ Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1558-63. PubMed ID: 16854285 [TBL] [Abstract][Full Text] [Related]
17. Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer. Tsuji T; Sawai T; Takeshita H; Nakagoe T; Hidaka S; Yamaguchi H; Yasutake T; Nagayasu T; Tagawa Y Cancer Chemother Pharmacol; 2004 Dec; 54(6):531-6. PubMed ID: 15309506 [TBL] [Abstract][Full Text] [Related]
18. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523 [TBL] [Abstract][Full Text] [Related]
19. [Tumoral levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in elderly colorectal cancer patients]. Ishida H; Takeuchi I; Inokuma S; Nakada H; Ohsawa T; Hoshino T; Murata N; Fujioka M; Hashimoto D; Idezuki Y Gan To Kagaku Ryoho; 2001 Jun; 28(6):809-14. PubMed ID: 11432349 [TBL] [Abstract][Full Text] [Related]
20. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study). Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]